-
Uncategorized2 months agoLilly’s AI commitment expands through deal with Insilico
A collaboration “across multiple therapeutic areas” could net the Hong Kong-based biotech more than $2 billion as Lilly seeks to sustain its industry lead. Read More
-
Uncategorized2 months ago
Viridian’s autoimmune eye disease shot passes Phase 3, but can it compete?
Viridian Therapeutics’ shares dropped Monday morning after a lackluster pivotal readout on its injection to treat thyroid eye disease. Viridian’s pitch is that its drug, known...
-
Uncategorized2 months ago
Blackstone raises $6.3B life sciences fund in record fundraising haul
The life sciences industry’s largest-ever private investment fund has arrived, and it comes from the world’s biggest alternative asset manager. On Monday, Blackstone announced it had...
-
Uncategorized2 months agoSTAT+: Early signs of Alzheimer’s often go undetected. These researchers want to change that
Researchers in Massachusetts are experimenting with artificial intelligence to detect signs of Alzheimer’s disease in its earliest stages, when symptoms of the dreaded illness may go...
-
Uncategorized2 months ago
Johnson & Johnson’s Impella pumps miss the mark in 2 major coronary studies
Two separate randomized trials failed to illustrate Impella’s benefits in specific cases of patients with blocked coronary arteries.
-
Uncategorized2 months agoEli Lilly and Insilico agree AI-driven drug discovery alliance
Eli Lilly and Insilico Medicine have announced a drug discovery collaboration that uses Insilico’s AI engine to accelerate the discovery and development of novel therapeutics across...
-
Uncategorized2 months ago
Eli Lilly to pay $115M upfront to Insilico in AI drug discovery deal
Another key player in China’s biotech ecosystem has landed a pharma deal. On Sunday, Eli Lilly and Insilico Medicine announced a drug discovery collaboration, with the...
-
Uncategorized2 months agoSTAT+: Biogen lupus drug improves skin clearance in mid-stage study
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Insilico Medicine signed a large...
-
Uncategorized2 months agoRaw dairy co. refutes connection to E. coli outbreak
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Good morning and happy Monday. I hope you...
-
Uncategorized2 months ago
Lilly Grows AI Footprint with Up-to-$2.75B Insilico Collaboration
Eli Lilly and Insilico Medicine are expanding a three-year partnership with a discovery and development collaboration that could generate more than $2.75 billion for the AI-based drug developer, Insilico said Sunday. Lilly has agreed...
STAT+: Updated: Tracking RFK Jr.’s promises to remake health in America
An obesity drug deep-dive, and peptides move mainstream
